Evidence quality 4.63/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 4/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 4/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
Brain aneurysms sit near the top of the "silent killer" anxiety hierarchy. The standard framing — "a time bomb in your head" — implies a ticking inevitability that could kill anyone at any moment. Viral social-media posts about young, apparently healthy people dying of ruptured aneurysms reinforce the sense that this is both common and unpreventable. Most adults, when pressed, will guess the lifetime risk is somewhere in the low single-digit percentages, conflating the prevalence of unruptured aneurysms (which really is a few percent) with the much smaller probability that one will actually rupture and kill.
Rough estimate: Most adults guess 2-5%, conflating aneurysm prevalence with fatal rupture
Source: editorial intuition, not polled
Actual
~6-9 per 100,000 adults per year (SAH incidence, US)
US adults (age 18+), subarachnoid haemorrhage from aneurysm rupture
Show derivation
Subarachnoid haemorrhage (SAH) incidence in the US is approximately 6-9 per 100,000 adults per year. The de Rooij et al. 2007 meta-analysis places the global figure at ~9/100k person-years; the 6-9/100k US range and the midpoint of 8 per 100,000 per year used here are the entry's own working assumptions. The AHA/ASA guideline cited below reports higher US figures (9.7 per 100,000 in some studies and 14.5 hospital discharges per 100,000 adults), so this assumption may understate US incidence. Case fatality for aneurysmal SAH is approximately 35% within 30 days hospital-based (up to ~50% including pre-hospital deaths). Both fatality figures are the entry's working assumptions; the AHA/ASA guideline cited below reports a median US mortality of 32% in epidemiological studies and does not state either of them. Annual mortality rate from ruptured aneurysm: 8/100,000 x 0.35 = 2.8 per 100,000 per year. Compounded over 59 years of remaining adult life (from age 18): 1 - (1 - 2.8e-5)^59 ≈ 0.00165. However, SAH incidence peaks in the 40-60 age range and the cumulative exposure across a full adult lifetime with age-weighted rates pushes the figure slightly higher. Adjusted to ~0.0025 (1 in 400) to account for the age-incidence curve peaking in middle age and for the fact that some SAH deaths occur in people who would have survived to old age absent the rupture. Uncertainty range reflects variation in incidence estimates (6-9/100k) and case-fatality estimates (30-50%).
Caveats: The headline number applies to a generic US adult with no known intracranial ane…
The headline number applies to a generic US adult with no known intracranial aneurysm. About 3% of adults unknowingly carry an unruptured aneurysm (Vlak et al. 2011), but the vast majority of these — especially small anterior-circulation aneurysms under 7mm — have a near-zero annual rupture rate (ISUIA 2003). The "time bomb in your head" metaphor radically overstates the danger for most incidental findings. Conversely, adults with large aneurysms (≥7mm), posterior-circulation aneurysms, family history of SAH, or ADPKD face meaningfully higher risk and should be managed per AHA/ASA guidelines. Case fatality has been declining over time as neurosurgical and endovascular techniques improve, so the 35% figure used here may overstate current mortality in well-resourced settings.
Related risks
Other risks on similar themes — for exploring related fears.
Unsafe imported products
What are the odds of being harmed by an unsafe imported consumer product?
Childhood cancer diagnosis
What are the odds of a child being diagnosed with cancer before age 20?
Counterfeit medicine
What are the odds of being harmed or killed by a counterfeit or substandard medicine?
COVID-19
What are the odds of dying from COVID-19 over the course of the pandemic and endemic era?
Pick challenger
About 3% of adults walk around with an unruptured intracranial aneurysm they don’t know about — roughly 1 in 30, per Vlak et al.’s 2011 meta-analysis in The Lancet Neurology. That number is real and well-established. What it does not mean is that 1 in 30 adults will die of a ruptured aneurysm. Subarachnoid haemorrhage from aneurysm rupture occurs at a rate of about 9 per 100,000 person-years worldwide (de Rooij et al. 2007); this entry assumes 6-9 per 100,000 adults per year for the US, and roughly a third of those cases are fatal (the AHA/ASA guidelines report a median US mortality of 32% in epidemiological studies, Connolly et al. 2012). Compounded over a full adult lifetime, that works out to approximately 1 in 400 — two orders of magnitude smaller than the prevalence figure that dominates the popular imagination.
The gap between prevalence and fatality is almost entirely explained by the ISUIA data: small aneurysms (under 7mm in the anterior circulation) have a five-year rupture rate that rounds to zero. Most incidental aneurysms found on MRI scans fall into this category. The “time bomb” metaphor collapses when you look at the size distribution — the overwhelming majority of aneurysms that exist will never rupture. The fear persists because the outcome when rupture does occur is catastrophic, and because prevalence and risk are easy to confuse when the subject is already frightening. It is a textbook case of dread risk: low probability, high consequence, vivid imagery, and no sense of personal control.
Where the number genuinely shifts: adults with a known aneurysm 7mm or larger, a family history of subarachnoid haemorrhage (two or more first-degree relatives), or autosomal dominant polycystic kidney disease all face materially elevated risk — roughly 4-8 times the population baseline, depending on the specific factor. For these subgroups, the AHA/ASA guidelines recommend screening and, in many cases, prophylactic treatment. For everyone else, the lifetime probability of dying from a ruptured brain aneurysm is in the same neighbourhood as drowning and well below car crashes, heart disease, or stroke.
Related tidbits
About 3% of adults carry an unruptured brain aneurysm, but the lifetime odds of dying from a rupture are roughly 1 in 400 for a US adult. Small anterior aneurysms under 7mm have a five-year rupture rate that rounds to zero.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] The Lancet Neurology (Vlak et al.) — Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis
Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis- Statistic
Overall prevalence of unruptured intracranial aneurysms in adults without comorbidity is 3.2% (95% CI 1.9-5.2%)- Excerpt
“"The overall prevalence was estimated as 3·2% (95% CI 1·9-5·2) in a population without comorbidity, with a mean age of 50 years, and consisting of 50% men. … Compared with populations without the comorbidity, PRs were 6·9 (95% CI 3·5-14) for autosomal dominant polycystic kidney disease (ADPKD)" ”
- Source data from
- 2011-01-05
- Accessed
- 2026-04-18 · archived copy
- Calculation
- Vlak et al. meta-analysis of 68 studies (83 study populations, 94,912 patients) establishes the 3.2% baseline prevalence of unruptured intracranial aneurysms. This figure anchors the "silent killer" perception: roughly 1 in 30 adults carries an aneurysm, but the annual rupture rate for small aneurysms is far lower than the prevalence implies. The prevalence figure is NOT the probability of dying — it is the denominator context for understanding why the fear is overrated.
-
[2] The Lancet (International Study of Unruptured Intracranial Aneurysms Investigators) — Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment (ISUIA)
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment (ISUIA)- Statistic
Five-year cumulative rupture rate for anterior circulation aneurysms <7mm was 0% in patients with no prior SAH; 2.6% for 7-12mm aneurysms- Excerpt
“"5-year cumulative rupture rates for patients who did not have a history of subarachnoid haemorrhage with aneurysms located in internal carotid artery, anterior communicating or anterior cerebral artery, or middle cerebral artery were 0%, 2. 6%, 14 5%, and 40% for aneurysms less than 7 mm, 7-12 mm, 13-24 mm, and 25 mm or greater, respectively" ”
- Source data from
- 2003-07-12
- Accessed
- 2026-04-18
- Calculation
- ISUIA prospective cohort (4,060 patients, 6,544 aneurysms) provides the natural-history rupture rates that underpin clinical management decisions. The 0% five-year rupture rate for small (<7mm) anterior aneurysms without prior SAH is the key datum explaining why incidental aneurysm findings rarely warrant emergency intervention, and why the gap between prevalence (3.2%) and fatal rupture (~0.25% lifetime) is so large.
-
[3] Journal of Neurology, Neurosurgery & Psychiatry (de Rooij et al.) — Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends
Incidence of subarachnoid haemorrhage: a systematic review with emphasis on region, age, gender and time trends- Statistic
Overall incidence of subarachnoid haemorrhage is approximately 9 per 100,000 person-years (9.1, 95% CI 8.8-9.5 in the reference group); ~22.7 in Japan and ~19.7 in Finland- Excerpt
“"Incidences per 100 000 person-years were 22.7 (95% CI 21.9 to 23.5) in Japan, 19.7 (18.1 to 21.3) in Finland, 4.2 (3.1 to 5.7) in South and Central America, and 9.1 (8.8 to 9.5) in the other regions. … The overall incidence of SAH is approximately 9 per 100 000 person-years." ”
- Source data from
- 2007-12-01
- Accessed
- 2026-04-18
- Calculation
- de Rooij et al. systematic review of 51 studies (45.8M person-years). Anchors the incidence term in the normalized calculation: overall SAH incidence ~9.1/100k person-years globally (reference group). The 6-9/100k US range used here is the entry's own working assumption, not a figure from this review. Case fatality (~35% at 30 days hospital-based, up to ~50% including pre-hospital deaths) is the entry's own working assumption; the AHA/ASA guideline below reports a median US mortality of 32%. Annual US mortality from ruptured aneurysm: ~8/100k incidence x 0.35 case fatality ≈ 2.8/100k/year. Over 59 remaining adult years: 1 - (1 - 2.8e-5)^59 ≈ 0.00165, adjusted upward to 0.0025 for age-incidence weighting.
-
[4] American Heart Association / American Stroke Association (Connolly et al.) — Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage- Statistic
US aSAH incidence reported as 9.7 per 100,000 in some studies and 14.5 hospital discharges per 100,000 adults (2003 Nationwide Inpatient Sample); median US mortality in epidemiological studies 32%; an estimated 12% to 15% of cases die before hospital admission- Excerpt
“"Although some reports have suggested the incidence of aSAH in the United States to be 9.7 per 100 000, the 2003 Nationwide Inpatient Sample provided an annual estimate of 14.5 discharges for aSAH per 100 000 adults. Because death resulting from aSAH often occurs before hospital admission (an estimated 12% to 15% of cases), the true incidence of aSAH might be even higher. [...] The median mortality rate in epidemiological studies from the United States has been 32% versus 43% to 44% in Europe and 27% in Japan." ”
- Source data from
- 2012-05-01
- Accessed
- 2026-04-18 · archived copy
- Calculation
- The guideline reports US incidence of 9.7 per 100,000 in some studies and 14.5 hospital discharges per 100,000 adults, and states that the true incidence may be higher because an estimated 12% to 15% of cases die before admission. It gives a median US mortality of 32% in epidemiological studies and notes that these studies did not always fully account for pre-hospital deaths. It is cited here only for these figures and for the clinical-management recommendations; the 6-9 per 100,000 incidence and the ~35% and ~50% case-fatality values used in the normalized calculation are the entry's own working assumptions, not figures stated in this guideline.







